SCHEMBL24590111

SCHEMBL24590111

C=CCN(C)c1ccc2c(C)cc(=O)oc2c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGLV6-57 P01721 6/20 0.71
▸ ALDH1A1 P00352 12/20 0.60
▸ HPGD P15428 10/20 0.60
▸ HSD17B10 Q99714 7/20 0.60
▸ GLA P06280 7/20 0.60
▸ CASP1 P29466 3/20 0.60
▸ CASP7 P55210 3/20 0.60
▸ L3MBTL1 Q9Y468 3/20 0.60
▸ CYP3A4 P08684 2/20 0.60
▸ MAPK1 P28482 1/20 0.60
▸ ATM Q13315 1/20 0.60
▸ HIF1A Q16665 1/20 0.60
▸ KDM4E B2RXH2 8/20 0.49
▸ GAA P10253 6/20 0.49
▸ CA9 Q16790 5/20 0.49
▸ CA12 O43570 4/20 0.49
▸ CA1 P00915 3/20 0.49
▸ CYP1A2 P05177 2/20 0.49
▸ CYP2C9 P11712 2/20 0.49
▸ LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1752667 0.88 ALDH1A1 (0.70) IGLV6-57ALDH1A1HPGDHSD17B10GLA
SCHEMBL22501627 0.87 IGLV6-57 (0.67) IGLV6-57ALDH1A1HPGDHSD17B10GLA
SCHEMBL22416802 0.83 IGLV6-57 (1.00) IGLV6-57ALDH1A1HPGDHSD17B10GLA
SCHEMBL22501571 0.81 IGLV6-57 (0.79) IGLV6-57ALDH1A1HPGDHSD17B10GLA
SCHEMBL24590085 0.80 IGLV6-57 (0.80) IGLV6-57ALDH1A1HPGDHSD17B10GLA
SCHEMBL22501692 0.80 IGLV6-57 (0.69) IGLV6-57ALDH1A1HPGDHSD17B10GLA
SCHEMBL67970 0.79 IGLV6-57 (0.72) IGLV6-57ALDH1A1HPGDHSD17B10GLA
SCHEMBL29401382 0.79 IGLV6-57 (0.72) IGLV6-57ALDH1A1HPGDHSD17B10GLA
SCHEMBL24589955 0.78 IGLV6-57 (0.78) IGLV6-57ALDH1A1HPGDHSD17B10GLA
SCHEMBL22501839 0.77 IGLV6-57 (0.69) IGLV6-57ALDH1A1HPGDHSD17B10GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS THE SCRIPPS RESEARCH INSTITUTE 2022-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS TTR, MAP1LC3B, SAAL1 IGLV6-57 7/4885ALDH1A1 2072/4885HPGD 3113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback